Abstract
Abnormal distributions of transition metals inside the brain are potential diagnostic markers for several central nervous system diseases, including Alzheimer’s disease (AD), Parkinson’s disease, dementia with Lewy bodies (DLB), bipolar disorders and depression. To further explore this possibility, the total concentrations of iron, zinc, copper, manganese, aluminum, chromium and cadmium were measured in post-mortem hippocampus and amygdala tissues taken from AD, DLB and Control patients. A statistically significant near fifty percent reduction in the total copper levels of AD patients was observed in both the hippocampus and amygdala. The statistical power of the hippocampus and amygdala copper analysis was found to be 86 and 74% respectively. No statistically significant deviations in the total metal concentrations were found for zinc, manganese, chromium or aluminum. Iron was found to be increased by 38% in AD amygdala tissues, but was unchanged in AD hippocampus tissues. Accounting for differences in tissue water content, as a function of both tissue type and disease state, revealed more consistencies with previous literature. To aid in the design of future experiments, the effect sizes for all tissue types and metals studied are also presented.
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10534-011-9504-8/MediaObjects/10534_2011_9504_Fig1_HTML.gif)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10534-011-9504-8/MediaObjects/10534_2011_9504_Fig2_HTML.gif)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10534-011-9504-8/MediaObjects/10534_2011_9504_Fig3_HTML.gif)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10534-011-9504-8/MediaObjects/10534_2011_9504_Fig4_HTML.gif)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10534-011-9504-8/MediaObjects/10534_2011_9504_Fig5_HTML.gif)
Similar content being viewed by others
References
Aamodt AH, Stovner LJ, Thorstensen K, Lydersen S, White LR, Aasly JO (2007) Prevalence of haemochromatosis gene mutations in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78:315–317
Akatsu H, Takahashi M, Matsukawa N et al (2002) Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 196:60–63
Andrási E, Farkas É, Scheibler H, Réffy A, Bezúr L (1995) Al, Zn, Cu, Mn and Fe levels in brain in Alheimer’s disease. Arch Gerontol Geriatr 21:89–97
Barthel H, Hermann W, Kluge R, Hesse S, Collingridge DR, Wagner A, Sabri O (2003) Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. Am J Neuroradiol 24:234–238
Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N, Mintz J (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28:414–423
Bartzokis G, Lu PH, Tishler TA et al (2010) Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J Alzheimers Dis 20:333–341
Becker JS, Zorly MV, Pickhardt C, Palomero-Gallagher N, Zilles K (2005) Imaging of copper, zinc, and other elements in thin section of human brain samples (hippocampus) by laser ablation inductively coupled plasma mass spectrometry. Anal Chem 77:3208–3216
Berg D, Hoggenmuller U, Hofmann E, Fischer R, Kraus M, Scheurlen M, Becker G (2000) The basal ganglia in haemochromatosis. Neuroradiology 42:9–13
Brewer GJ (2010a) Copper toxicity in the general population. Clin Neurophysiol 121:459–460
Brewer GJ (2010b) Risks of copper and iron toxicity during aging in humans. Chem Res Toxicol 23:319–326
Castellani RJ, Siedlak SL, Perry G, Smith MA (2000) Sequestration of iron by Lewy bodies in Parkinson’s disease. Acta Neuropathol 100:111–114
Cohen J (1988) Statistical power analysis for the behavioral sciences. Psychology Press, New York
Corrigan FM, Reynolds GP, Ward NI (1993) Hippocampal tin, aluminum and zinc in Alzheimer’s disease. Biometals 6:149–154
Crouch PJ, Huang LW, Adlard PA et al (2009) Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. PNAS 106:381–386
Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress. J Neurol Sci 143:137–142
Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953–1975
Dexter DT, Sain J, Rose S et al (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35:38–44
Dingwall C (2007) A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer’s disease. Biochem Soc Trans 35:571–573
Grunberg-Etkovitz N, Lev N, Ickowicz D, Avital A, Offen D, Malik Z (2009) Accelerated proteasomal activity inducted by Pb(+2), Ga(+3), or Cu(+2) exposure does not induce degradation of alpha-synuclein. J Environ Pathol Toxicol Oncol 28:5–24
Heit M, Klusek CS (1982) The effects of dissecting tools on the trace element concentrations of fish and mussel tissues. Sci Total Environ 24:129–134
Kitzberger R, Madl C, Ferenci P (2005) Wilson disease. Metab Brain Dis 20:295–302
Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer’s disease senile plaques. J Neurol Sci 158:47–52
Moody JR, Lindstrom RM (1977) Selection and cleaning of plastic containers for storage of trace element samples. Anal Chem 49:2264–2267
Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, Beyreuther K (1996) The amyloid precursor protein of Alzheimer’s disease in the reduction of copper(II) to copper(I). Science 271:1406–1409
Mustak MS, Rao TSS, Shanmugavelu P, Sundar NMS, Menon RB, Rao RV, Rao KSJ (2008) Assessment of serum macro and trace element homeostasis and the complexity of inter-element relations in bipolar mood disorders. Clinica Chimica Acta 394:47–53
Panayi AE, Spyrou NM, Iversen BS, White MA, Part P (2002) Determination of cadmium and zinc in Alzheimer’s brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci 195:1–10
Paris I, Dagnino-Subiabre A, Marcelain K, Bennett LB, Caviedes P, Caviedes R, Olea-Azar C, Segura-Aguilar J (2001) Copper neurotoxicity is dependent on dopamine-mediated copper uptake and one-electron reduction of aminochrome in rat substantia nigra neuronal cell line. J Neurochem 77:519–529
Perry R, McKeith I, Perry E (1997) Lewy body dementia-clinical, pathological and neurochemical interconnections. J Neural Transm 51:95–109
Plantin L-O, Lying-Tunell U, Kristensson K (1987) Trace elements in the human central nervous system studied with neuron activation analysis. Biol Trace Elem Res 13:69–75
Roelandts I, Gladney ES (1998) Consensus values for NIST biological and environmental standard reference materials. Fresenius J Anal Chem 360:327–338
Rulon LL, Robertson JD, Lovell MA, Deibel MA, Ehmann WD, Markesbery WR (2000) Serum zinc levels and Alzheimer’s disease. Biol Trace Elem Res 75:79–85
Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. PNAS 94:9866–9868
Squitti R, Pasqualetti P, Forno GD et al (2005) Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 64:1040–1046
Squitti R, Barbati G, Rossi L et al (2006) Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF beta-amyloid, and h-tau. Neurology 67:76–82
Squitti R, Bressi F, Pasqualetti P et al (2009) Longitudinal prognostic value of serum “free” copper in patients with Alzheimer disease. Neurology 72:50–55
Strozyk D, Launer LJ, Adlard PA et al (2007) Zinc and copper module Alzheimer ABeta levels in human cerebrospinal fluid. Neurobiol Aging 30:1069–1077
Ward NI, Mason JA (1987) Neutron activation analysis techniques for identifying elemental status in Alzheimer’s disease. J Radioanal Nucl Chem 113:515–526
Acknowledgments
The authors would like to sincerely thank both the patients and their families for their generous donations, without which this research would not be possible. The authors would like to acknowledge the researchers at Elemental Analysis Inc. (Kentucky, USA) for their invaluable assistance with the inductively coupled mass spectrometry experiments. The authors would also like to acknowledge financial support from the New Energy and Industrial Technology Development Organization (Tokyo, Japan).
Author information
Authors and Affiliations
Corresponding author
Additional information
E. M. Yezdimer—formerly at Industrial Summit Technology
Rights and permissions
About this article
Cite this article
Akatsu, H., Hori, A., Yamamoto, T. et al. Transition metal abnormalities in progressive dementias. Biometals 25, 337–350 (2012). https://doi.org/10.1007/s10534-011-9504-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-011-9504-8